Angiosarcoma is rare, and often portends adverse outcomes. Those who receives multi-modal care generally experience the best cancer outcomes. However, guidelines to inform approach are limited. Further education is needed to advocate for high-quality care in this uncommon setting.

This presentation reviews characteristic multimodality imaging features of soft tissue sarcoma (STS), discusses MRI imaging protocols, identifies imaging features of STS that may allow for a specific diagnosis or narrow the differential diagnosis, covers potential imaging pitfalls, and discusses

There are many ongoing advances in the context of radiation therapy delivery for patients with primary soft tissue sarcoma of the extremity/trunk with emerging practice-changing clinical research and new treatment options, some of which are not yet standard of care.

This presentation reviews characteristic multimodality imaging features of soft tissue sarcoma (STS), discusses MRI imaging protocols, identifies imaging features of STS that may allow for a specific diagnosis or narrow the differential diagnosis, covers potential imaging pitfalls, and discusses

Angiosarcoma is rare, and often portends adverse outcomes. Those who receives multi-modal care generally experience the best cancer outcomes. However, guidelines to inform approach are limited. Further education is needed to advocate for high-quality care in this uncommon setting.

Sarcomas are a rare and heterogenous group of malignancies requiring a multidisciplinary approach for optimal management.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.